UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
CINC holding history
CinCor Pharma, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CINC overviewAll 13F holders of CINCFull Q2 2026 holdings
- Shares (Q1 2023)
- 0
- Sold out in Q1 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2023 | 0 | $0 | 0.0% | −138,614−100.0% | Sold out | Holders |
| Q4 2022 | 138,614 | $1.70M | <0.1% | +115,690+504.7% | Added | Holders |
| Q3 2022 | 22,924 | $753.0K | <0.1% | +22,052+2,528.9% | Added | Holders |
| Q2 2022 | 872 | $16.0K | <0.1% | −1,283−59.5% | Reduced | Holders |
| Q1 2022 | 2,155 | $38.0K | <0.1% | +2,155 | New | Holders |